Regeneron Pharmaceuticals said Friday it has paused a clinical study of its antibody drug to treat some of the sickest COVID-19 patients because of a potential safety concern.
Trending:
Regeneron halts trial of COVID-19 antibody drug in sickest hospitalized patients